Literature DB >> 389121

Disulfiram for the treatment of alcoholism. An evaluation in 128 men.

R K Fuller, H P Roth.   

Abstract

One hundred twenty-eight alcoholic men were assigned randomly to receive either a regular dose of disulfiram (250 mg), a pharmacologically inactive dose (1 mg), or no disulfiram. There were no statistically significant differences among the three treatment groups in total abstinence, percentage of drinking days, days worked, family stability (living with same relative), or percent of scheduled appointments kept. However, 21% of those who received the regular dose of disulfiram and 25% who received the pharmacologically inactive dose remained abstinent, whereas only 12% of those who received no disulfiram did so. These results indicate that disulfiram may be of limited value in the treatment of alcoholism, fear of the disulfiram-ethanol reaction is important in preventing drinking, and patients willing to take disulfiram are more likely to be abstinent if given the drug. We also found that complete abstinence correlated significantly with compliance and obtaining employment.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 389121     DOI: 10.7326/0003-4819-90-6-901

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  10 in total

Review 1.  Disulfiram treatment for alcoholism.

Authors:  N Heather
Journal:  BMJ       Date:  1989-08-19

Review 2.  Clinical issues related to the costs of alcoholism.

Authors:  M O Howard; R W McGuffin; A J Saxon; K L Sloan; R D Walker
Journal:  Pharmacoeconomics       Date:  1996-02       Impact factor: 4.981

Review 3.  Medical treatment of alcohol dependence: a systematic review.

Authors:  Peter M Miller; Sarah W Book; Scott H Stewart
Journal:  Int J Psychiatry Med       Date:  2011       Impact factor: 1.210

4.  Gender differences in clinical outcomes for cocaine dependence: randomized clinical trials of behavioral therapy and disulfiram.

Authors:  Elise E DeVito; Theresa A Babuscio; Charla Nich; Samuel A Ball; Kathleen M Carroll
Journal:  Drug Alcohol Depend       Date:  2014-10-20       Impact factor: 4.492

5.  OLITA: an alternative in the treatment of therapy-resistant chronic alcoholics. First evaluation of a new approach.

Authors:  H Ehrenreich; A Mangholz; M Schmitt; P Lieder; W Völkel; E Rüther; W Poser
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

Review 6.  Alcohol liver disease: A review of current therapeutic approaches to achieve long-term abstinence.

Authors:  María Luisa Gutiérrez García; Sara Blasco-Algora; Conrado M Fernández-Rodríguez
Journal:  World J Gastroenterol       Date:  2015-07-28       Impact factor: 5.742

7.  Sex differences in cocaine-dependent individuals' response to disulfiram treatment.

Authors:  Charla Nich; Elinore F McCance-Katz; Ismene L Petrakis; Joseph F Cubells; Bruce J Rounsaville; Kathleen M Carroll
Journal:  Addict Behav       Date:  2004-08       Impact factor: 3.913

8.  Disulfiram efficacy in the treatment of alcohol dependence: a meta-analysis.

Authors:  Marilyn D Skinner; Pierre Lahmek; Héloïse Pham; Henri-Jean Aubin
Journal:  PLoS One       Date:  2014-02-10       Impact factor: 3.240

Review 9.  Alcoholism treatment in the United States. An overview.

Authors:  R K Fuller; S Hiller-Sturmhöfel
Journal:  Alcohol Res Health       Date:  1999

Review 10.  Therapeutic options and challenges for substances of abuse.

Authors:  Tracie J Gardner; Thomas R Kosten
Journal:  Dialogues Clin Neurosci       Date:  2007       Impact factor: 5.986

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.